文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

在刚果民主共和国偏远地区设立埃博拉疫苗试验:挑战、缓解措施与经验教训

Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
PubMed 文献 · Vaccine · 2022-05-09

本文介绍了由欧盟创新药物计划与流行病防范创新联盟资助的EBOVAC3联盟在刚果民主共和国偏远地区开展埃博拉疫苗试验时遇到的挑战、缓解措施、建议与经验教训。挑战分为监管、政治与伦理,试验文件,国际合作,当地试验人员,社区参与与宣传,后勤,偏远与气候条件,财务八类。通过分享这些经验,作者希望帮助其他研究人员在类似中低收入国家的偏远地区建立运作良好的临床试验单位。

要点

  • 在刚果民主共和国偏远地区设立埃博拉疫苗试验面临监管、政治与伦理等八类挑战。
  • EBOVAC3联盟通过广泛的南北合作促成中非和西非高质量疫苗试验。
  • 分享挑战、缓解措施与经验教训旨在帮助类似偏远地区的研究者。

核心结论

  • 通过分享在刚果民主共和国偏远地区设立埃博拉疫苗试验中遇到的挑战、实施的缓解措施与经验教训,作者希望帮助其他研究人员在类似中低收入国家的偏远地区建立运作良好的临床试验单位。

研究设计与样本

  • 本文介绍了EBOVAC3联盟在刚果民主共和国偏远地区设立埃博拉疫苗试验时遇到的挑战、缓解措施、建议与经验教训,该联盟由欧盟创新药物计划与流行病防范创新联盟资助。

主要发现

  • 遇到的挑战被归纳为八个类别:监管、政治与伦理,试验文件,国际合作,当地试验人员,社区参与与宣传,后勤,偏远与气候条件,财务。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since the largest Ebola outbreak in West Africa (2013-2016) highlighted the potential threat of the Ebola virus to the world, several vaccines have been under development by different pharmaceutical companies. To obtain vaccine licensure, vaccine trials assessing the safety, immunogenicity and efficacy of new vaccines among different populations (e.g. different in age, gender, race, and ethnicity) play a crucial role. However, while this deadly disease mainly affects Central and West Africa, clinical trial regulations are becoming increasingly complex and consequently more expensive, influencing the affected low- and middle-income countries (LMICs) in performing high quality clinical trials. Consequently, the completion of such trials in LMICs takes more time and vaccines and drugs take longer to be licensed. To overcome some of the obstacles faced, the EBOVAC3 consortium, funded by the European Union's Innovative Medicines Initiative and the Coalition for Epidemic Preparedness Innovations, enabled high quality vaccine trials in Central and West Africa through extensive North-South collaborations. In this article, the encountered challenges, mitigations, recommendations and lessons learned from setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of Congo are presented. These challenges are grouped into eight categories: (1) Regulatory, political and ethical, (2) Trial documents, (3) International collaborations, (4) Local trial staff, (5) Community engagement and sensitization, (6) Logistics, (7) Remoteness and climate conditions, (8) Financial. By sharing the encountered challenges, implemented mitigations and lessons learned for each of these categories, we hope to prepare and inform other researchers aspiring a well-functioning clinical trial unit in similar remote settings in LMICs. ClinicalTrials.gov identifier: NCT04186000.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zola Matuvanga T, Larivière Y, Lemey G, et al. Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned. Vaccine. 2022. PMID: 35550847. doi:10.1016/j.vaccine.2022.04.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。